医护人员麻疹免疫:疫苗接种与抗体筛查策略比较
德国一项法律要求1970年后出生的医护人员记录两剂麻疹疫苗或麻疹血清阳性,常设疫苗接种委员会将其扩展为两剂麻腮风疫苗推荐。研究评估386名医护人员麻腮风血清状态,发现麻疹IgG血清阳性率72%。结论认为,无或仅一剂麻疹疫苗记录者接种前筛查最具成本效益,但以麻腮风免疫为目标时直接接种最经济。
要点
- 386名医护人员麻疹IgG血清阳性率为72%,低于75%。
- 无、一剂、两剂麻疹疫苗记录者麻疹IgG阳性率分别为77%、74%、61%(p<0.05)。
- 两剂疫苗记录者ELISA可能低估保护,无需血清学检测;以麻腮风免疫为目标时直接接种最经济。
核心结论
- 医护人员麻疹血清阳性率低于75%;两剂疫苗记录者无需ELISA血清学检测;以麻疹免疫为目标时,无或一剂记录者接种前筛查最具成本效益;以麻腮风免疫为目标时,不筛查直接接种最具成本效益且具重要获益。
研究设计与样本
- 2020年11月至2021年7月,在职业健康服务部门对386名进行入职前或常规职业检查的医护人员评估麻腮风血清状态,收集社会人口学和疫苗接种记录数据。
主要发现
- 总体麻疹IgG血清阳性率为72%。
- 无、一剂和两剂麻疹疫苗记录者的麻疹IgG阳性率分别为77%、74%和61%(p<0.05)。
- 无和一剂麻疹疫苗记录者的麻腮风血清阳性率分别为66%和58%。
- 仅考虑麻疹免疫时,接种前抗麻疹IgG筛查节省成本;考虑麻腮风血清阳性时,接种前筛查不具成本效益。
- 定量病灶减少中和试验显示,两剂麻疹疫苗记录但ELISA IgG阴性或临界者具有免疫力。
临床怎么用
- 以麻疹免疫为目标时,对无或一剂麻疹疫苗记录的医护人员,接种前麻疹血清学筛查最具成本效益。
- 以麻腮风免疫为目标时,对无血清学筛查的医护人员直接接种最具成本效益,且不应忽视其重要获益。
- 对有兩剂麻疹疫苗记录者,ELISA检测会低估保护,因此无需血清学检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To promote measles protection in community and health care facilities a law (Measles Protection act, MPA) came into force in Germany requiring documentation of two measles vaccinations or evidence of measles seropositivity for healthcare workers (HCW) born after 1970. The German Standing Committee on Vaccination extended this law to a recommendation of two measles, mumps, rubella (MMR) vaccinations. Our aim was to evaluate serology-based vaccination strategies for measles and to consider their extension to mumps and rubella. SUBJECT AND METHODS: Between 11/2020-7/2021, MMR serostatus was assessed in 386 HCW attending the Occupational Health Service Department for pre-employment or regular occupational examinations. Sociodemographic and documented vaccination data were collected. RESULTS: Overall, measles IgG seropositivity was 72 %. Measles IgG was found in 77 %, 74 % and 61 % of employees with no, one and two documented measles vaccinations, respectively (p < 0.05). Seropositivity against MMR was detected in 66 % and 58 % with no and one documented measles vaccination, respectively. Considering measles immunity only anti-measles IgG screening prior vaccination saved costs. However, considering MMR seropositivity screening prior vaccination was not cost-effective. Measurement of measles virus neutralizing potency using a quantitative focus reduction neutralization assay to measure measles virus neutralizing potency indicated immunity in persons with two documented measles vaccine doses but negative or equivocal ELISA IgG results. CONCLUSION: Measles seropositivity was below 75 % among HCW. In individuals with documentation of two measles vaccine doses ELISA tests underestimate protection, thus no serological testing is needed. Considering measles seropositivity in HCW with no or one documented measles vaccination, measles serological screening before vaccination was most cost-effective. However, aiming at MMR immunity, vaccination of HCW without serological screening was most cost-effective and offers important benefits that should not be dismissed.
引用
- Schieferdecker R, Menting T, Mankertz A, et al. Vaccination versus antibody screening for measles immunity in health care workers. Vaccine. 2025. PMID: 41072277. doi:10.1016/j.vaccine.2025.127845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。